Jiangsu Hengrui Medicine
600276.SS
£4.95
Share price
-0.13%
Change (1 day)
-4.10%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
Jiangsu Hengrui Medicine (600276.SS) - Net assets
Net assets on the balance sheet as of September 2024 : £4.86 Billion
According to Jiangsu Hengrui Medicine
's latest financial reports the company has £4.86 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Jiangsu Hengrui Medicine - Net assets on balance sheet (from 2001 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $£4.55 B | -1.03% |
| 2022-12-31 | $£4.60 B | 11.32% |
| 2021-12-31 | $£4.13 B | 19.42% |
| 2020-12-31 | $£3.46 B | 27.21% |
| 2019-12-31 | $£2.72 B | 19.27% |
| 2018-12-31 | $£2.28 B | 25.88% |
| 2017-12-31 | $£1.81 B | 20.67% |
| 2016-12-31 | $£1.50 B | 39.34% |
| 2015-12-31 | $£1.07 B | 27.5% |
| 2014-12-31 | $£0.84 B | 26.85% |
| 2013-12-31 | $£0.66 B | 23.46% |
| 2012-12-31 | $£0.54 B | 20.49% |
| 2011-12-31 | $£0.44 B | 31.67% |
| 2010-12-31 | $£0.34 B | 41.19% |
| 2009-12-31 | $£0.24 B | 18.93% |
| 2008-12-31 | $£0.20 B | 77.48% |
| 2007-12-31 | $£0.11 B | 37.81% |
| 2006-12-31 | $£82.88 M | 4.07% |
| 2005-12-31 | $£79.64 M | 26.64% |
| 2004-12-31 | $£62.88 M | 2.95% |
| 2003-12-31 | $£61.08 M | 0.09% |
| 2002-12-31 | $£61.03 M | -3.38% |
| 2001-12-31 | $£63.16 M |